Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3KÎ´ inhibitor therapy.

Mato, Anthony R; Ghosh, Nilanjan; Schuster, Stephen J; Lamanna, Nicole; Pagel, John M; Flinn, Ian W; Barrientos, Jacqueline C; Rai, Kanti R; Reeves, James A; Cheson, Bruce D; Barr, Paul M; Kambhampati, Suman; Lansigan, Frederick; Pu, Jeffrey J; Skarbnik, Alan P; Roeker, Lindsey; Fonseca, Gustavo A; Sitlinger, Andrea; Hamadeh, Issam S; Dorsey, Colleen; LaRatta, Nicole; Weissbrot, Hanna; Luning Prak, Eline T; Tsao, Patricia; Paskalis, Dana; Sportelli, Peter; Miskin, Hari P; Weiss, Michael S; Svoboda, Jakub; Brander, Danielle M.

Blood ; 137(20): 2817-2826, 2021 05 20.

Artículo en Inglés | MEDLINE | ID: mdl-33259589

2.

The effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation.

Moreb, Jan S; Lantos, Lori; Chen, Franklin; Elliott, Kathleen; Dugan, James; Skarbnik, Alan P; Kropf, Patricia Lamont; Ward, Kimberly.

Transfus Apher Sci ; 62(6): 103787, 2023 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-37704508

3.

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

Eyre, Toby A; Roeker, Lindsey E; Fox, Christopher P; Gohill, Satyen H; Walewska, Renata; Walter, Harriet S; Forconi, Francesco; Broom, Angus; Arumainathan, Arvind; Brander, Danielle M; Allan, John N; Schuster, Stephen J; Hill, Brian T; Lansigan, Frederick; Cheson, Bruce D; Lamanna, Nicole; Coombs, Catherine C; Barr, Paul M; Skarbnik, Alan P; Shadman, Mazyar; Ujjani, Chaitra S; Pearson, Laurie; Pagel, John M; Jacobs, Ryan; Mato, Anthony R.

Br J Haematol ; 188(6): 918-923, 2020 03.

Artículo en Inglés | MEDLINE | ID: mdl-31682002

4.

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.

Flinn, Ian W; Hillmen, Peter; Montillo, Marco; Nagy, Zsolt; Illés, Árpád; Etienne, Gabriel; Delgado, Julio; Kuss, Bryone J; Tam, Constantine S; Gasztonyi, Zoltán; Offner, Fritz; Lunin, Scott; Bosch, Francesco; Davids, Matthew S; Lamanna, Nicole; Jaeger, Ulrich; Ghia, Paolo; Cymbalista, Florence; Portell, Craig A; Skarbnik, Alan P; Cashen, Amanda F; Weaver, David T; Kelly, Virginia M; Turnbull, Barry; Stilgenbauer, Stephan.

Blood ; 132(23): 2446-2455, 2018 12 06.

Artículo en Inglés | MEDLINE | ID: mdl-30287523

5.

Current landscape for chimeric antigen receptor T cells in lymphomas.

Skarbnik, Alan P.

Curr Opin Hematol ; 26(6): 421-426, 2019 11.

Artículo en Inglés | MEDLINE | ID: mdl-31483334

6.

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

Mato, Anthony R; Nabhan, Chadi; Barr, Paul M; Ujjani, Chaitra S; Hill, Brian T; Lamanna, Nicole; Skarbnik, Alan P; Howlett, Christina; Pu, Jeffrey J; Sehgal, Alison R; Strelec, Lauren E; Vandegrift, Alexandra; Fitzpatrick, Danielle M; Zent, Clive S; Feldman, Tatyana; Goy, Andre; Claxton, David F; Bachow, Spencer Henick; Kaur, Gurbakhash; Svoboda, Jakub; Nasta, Sunita Dwivedy; Porter, David; Landsburg, Daniel J; Schuster, Stephen J; Cheson, Bruce D; Kiselev, Pavel; Evens, Andrew M.

Blood ; 128(18): 2199-2205, 2016 11 03.

Artículo en Inglés | MEDLINE | ID: mdl-27601462

7.

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.

Mato, Anthony R; Thompson, Meghan; Allan, John N; Brander, Danielle M; Pagel, John M; Ujjani, Chaitra S; Hill, Brian T; Lamanna, Nicole; Lansigan, Frederick; Jacobs, Ryan; Shadman, Mazyar; Skarbnik, Alan P; Pu, Jeffrey J; Barr, Paul M; Sehgal, Alison R; Cheson, Bruce D; Zent, Clive S; Tuncer, Hande H; Schuster, Stephen J; Pickens, Peter V; Shah, Nirav N; Goy, Andre; Winter, Allison M; Garcia, Christine; Kennard, Kaitlin; Isaac, Krista; Dorsey, Colleen; Gashonia, Lisa M; Singavi, Arun K; Roeker, Lindsey E; Zelenetz, Andrew; Williams, Annalynn; Howlett, Christina; Weissbrot, Hanna; Ali, Naveed; Khajavian, Sirin; Sitlinger, Andrea; Tranchito, Eve; Rhodes, Joanna; Felsenfeld, Joshua; Bailey, Neil; Patel, Bhavisha; Burns, Timothy F; Yacur, Melissa; Malhotra, Mansi; Svoboda, Jakub; Furman, Richard R; Nabhan, Chadi.

Haematologica ; 103(9): 1511-1517, 2018 09.

Artículo en Inglés | MEDLINE | ID: mdl-29880613

8.

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.

Mato, Anthony R; Roeker, Lindsey E; Allan, John N; Pagel, John M; Brander, Danielle M; Hill, Brian T; Cheson, Bruce D; Furman, Richard R; Lamanna, Nicole; Tam, Constantine S; Handunnetti, Sasanka; Jacobs, Ryan; Lansigan, Frederick; Bhavsar, Erica; Barr, Paul M; Shadman, Mazyar; Skarbnik, Alan P; Goy, Andre; Beach, Douglas F; Svoboda, Jakub; Pu, Jeffrey J; Sehgal, Alison R; Zent, Clive S; Tuncer, Hande H; Schuster, Stephen J; Pickens, Peter V; Shah, Nirav N; Rhodes, Joanna; Ujjani, Chaitra S; Nabhan, Chadi.

Am J Hematol ; 93(11): 1394-1401, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-30132965

9.

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.

Treon, Steven P; Castillo, Jorge J; Skarbnik, Alan P; Soumerai, Jacob D; Ghobrial, Irene M; Guerrera, Maria Luisa; Meid, Kirsten; Yang, Guang.

Blood ; 135(21): 1912-1915, 2020 05 21.

Artículo en Inglés | MEDLINE | ID: mdl-32302379

10.

A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma.

Biran, Noa; Rowley, Scott D; Vesole, David H; Zhang, Shijia; Donato, Michele L; Richter, Joshua; Skarbnik, Alan P; Pecora, Andrew; Siegel, David S.

Biol Blood Marrow Transplant ; 22(12): 2165-2171, 2016 12.

Artículo en Inglés | MEDLINE | ID: mdl-27590107

11.

Mantle cell lymphoma: state of the art.

Skarbnik, Alan P; Goy, Andre H.

Clin Adv Hematol Oncol ; 13(1): 44-55, 2015 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-25679973

12.

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.

Miklos, David Bernard; Abu Zaid, Mohammad; Cooney, Julian P; Albring, Jörn C; Flowers, Mary; Skarbnik, Alan P; Yakoub-Agha, Ibrahim; Ko, Bor-Sheng; Bruno, Benedetto; Waller, Edmund K; Yared, Jean; Sohn, Sang Kyun; Bulabois, Claude-Eric; Teshima, Takanori; Jacobsohn, David; Greinix, Hildegard; Mokatrin, Ahmad; Lee, Yihua; Wahlstrom, Justin T; Styles, Lori; Socie, Gerard.

J Clin Oncol ; 41(10): 1876-1887, 2023 04 01.

Artículo en Inglés | MEDLINE | ID: mdl-36608310

13.

Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation.

Skarbnik, Alan P; Donato, Michele L; Feinman, Rena; Rowley, Scott D; Vesole, David H; Goy, Andre H; Munshi, Pashna N; Feldman, Tatyana; Leslie, Lori A; Biran, Noa; Nyirenda, Themba; Fields, Paul A; Descalzi-Montoya, Dante; Zenreich, Joshua; Korngold, Robert; Pecora, Andrew L.

Transplant Cell Ther ; 27(5): 391-403, 2021 05.

Artículo en Inglés | MEDLINE | ID: mdl-33965177

14.

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.

Cuneo, Antonio; Mato, Anthony R; Rigolin, Gian Matteo; Piciocchi, Alfonso; Gentile, Massimo; Laurenti, Luca; Allan, John N; Pagel, John M; Brander, Danielle M; Hill, Brian T; Winter, Allison; Lamanna, Nicole; Tam, Constantine S; Jacobs, Ryan; Lansigan, Frederick; Barr, Paul M; Shadman, Mazyar; Skarbnik, Alan P; Pu, Jeffrey J; Sehgal, Alison R; Schuster, Stephen J; Shah, Nirav N; Ujjani, Chaitra S; Roeker, Lindsey; Orlandi, Ester Maria; Billio, Atto; Trentin, Livio; Spacek, Martin; Marchetti, Monia; Tedeschi, Alessandra; Ilariucci, Fiorella; Gaidano, Gianluca; Doubek, Michael; Farina, Lucia; Molica, Stefano; Di Raimondo, Francesco; Coscia, Marta; Mauro, Francesca Romana; de la Serna, Javier; Medina Perez, Angeles; Ferrarini, Isacco; Cimino, Giuseppe; Cavallari, Maurizio; Cucci, Rosalba; Vignetti, Marco; Foà, Robin; Ghia, Paolo.

Cancer Med ; 9(22): 8468-8479, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32969597

15.

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.

Mato, Anthony R; Roeker, Lindsey E; Jacobs, Ryan; Hill, Brian T; Lamanna, Nicole; Brander, Danielle; Shadman, Mazyar; Ujjani, Chaitra S; Yazdy, Maryam Sarraf; Perini, Guilherme Fleury; Pinilla-Ibarz, Javier A; Barrientos, Jacqueline; Skarbnik, Alan P; Torka, Pallawi; Pu, Jeffrey J; Pagel, John M; Gohil, Satyen; Fakhri, Bita; Choi, Michael; Coombs, Catherine C; Rhodes, Joanna; Barr, Paul M; Portell, Craig A; Parry, Helen; Garcia, Christine A; Whitaker, Kate J; Winter, Allison M; Sitlinger, Andrea; Khajavian, Sirin; Grajales-Cruz, Ariel F; Isaac, Krista M; Shah, Pratik; Akhtar, Othman S; Pocock, Rachael; Lam, Kentson; Voorhees, Timothy J; Schuster, Stephen J; Rodgers, Thomas D; Fox, Christopher P; Martinez-Calle, Nicolas; Munir, Talha; Bhavsar, Erica B; Bailey, Neil; Lee, Jason C; Weissbrot, Hanna B; Nabhan, Chadi; Goodfriend, Julie M; King, Amber C; Zelenetz, Andrew D; Dorsey, Colleen.

Clin Cancer Res ; 26(14): 3589-3596, 2020 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-32198151

16.

A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma.

Biran, Noa; Rowley, Scott D; Vesole, David H; Zhang, Shijia; Donato, Michele L; Skarbnik, Alan P; Richter, Joshua; Pecora, Andrew; Siegel, David S.

Bone Marrow Transplant ; 54(11): 1881-1891, 2019 11.

Artículo en Inglés | MEDLINE | ID: mdl-31101891

17.

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.

Mato, Anthony R; Roeker, Lindsey E; Eyre, Toby A; Nabhan, Chadi; Lamanna, Nicole; Hill, Brian T; Brander, Danielle M; Barr, Paul M; Lansigan, Frederick; Cheson, Bruce D; Singavi, Arun K; Yazdy, Maryam Sarraf; Shah, Nirav N; Allan, John N; Bhavsar, Erica B; Rhodes, Joanna; Kennard, Kaitlin; Schuster, Stephen J; Williams, AnnaLynn M; Skarbnik, Alan P; Goy, Andre H; Goodfriend, Julie M; Dorsey, Colleen; Coombs, Catherine C; Tuncer, Hande; Ujjani, Chaitra S; Jacobs, Ryan; Winter, Allison M; Pagel, John M; Bailey, Neil; Schuh, Anna; Shadman, Mazyar; Sitlinger, Andrea; Weissbrot, Hanna; Muralikrishnan, Sivraj; Zelenetz, Andrew; Kirkwood, Amy A; Fox, Christopher P.

Blood Adv ; 3(10): 1568-1573, 2019 05 28.

Artículo en Inglés | MEDLINE | ID: mdl-31101647

18.

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.

Roeker, Lindsey E; Fox, Christopher P; Eyre, Toby A; Brander, Danielle M; Allan, John N; Schuster, Stephen J; Nabhan, Chadi; Hill, Brian T; Shah, Nirav N; Lansigan, Frederick; Yazdy, Maryam; Cheson, Bruce D; Lamanna, Nicole; Singavi, Arun K; Coombs, Catherine C; Barr, Paul M; Skarbnik, Alan P; Shadman, Mazyar; Ujjani, Chaitra S; Tuncer, Hande H; Winter, Allison M; Rhodes, Joanna; Dorsey, Colleen; Morse, Hannah; Kabel, Charlene; Pagel, John M; Williams, Annalynn M; Jacobs, Ryan; Goy, Andre; Muralikrishnan, Sivraj; Pearson, Laurie; Sitlinger, Andrea; Bailey, Neil; Schuh, Anna; Kirkwood, Amy A; Mato, Anthony R.

Clin Cancer Res ; 25(14): 4264-4270, 2019 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-31004001

19.

The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies.

Skarbnik, Alan P; Faderl, Stefan.

Ther Adv Hematol ; 8(3): 99-105, 2017 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-28246553

20.

Targeting indolent non-Hodgkin lymphoma.

Leslie, Lori A; Skarbnik, Alan P; Bejot, Coleen; Stives, Susan; Feldman, Tatyana A; Goy, Andre H.

Expert Rev Hematol ; 10(4): 299-313, 2017 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-28277849

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: